CGCABLE
834639
KLT
831689
DAYU BIOLOGICAL
871970
4
Fujian Superpipe
300198
5
WuHan Hvsen Biotechnology
300871
CN Stock MarketDetailed Quotes
300824 Shenzhen Crastal Technology
- 10.10
- +0.24+2.43%
Market Closed Mar 26 15:00 CST
3.30BMarket Cap47.42P/E (TTM)
10.20High9.79Low57.57KlotVolume9.82Open9.86Pre Close57.87MTurnover1.82%Turnover Ratio47.42P/E (Static)326.34MShares11.4552wk High4.68P/B3.19BFloat Cap6.3852wk Low11.83Limit Up316.05MShs Float26.44Historical High7.89Limit Down4.16%Amplitude3.84Historical Low0.28Dividend TTM10.05Avg Price27.00KlotAsk2.77%Div YieldTTM100Lot Size28.14KlotBid
Shenzhen Crastal Technology Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 13.28%753.62M | 7.19%506.29M | 0.22%322.13M | -6.52%159.36M | -17.33%665.28M | -11.73%472.32M | -12.86%321.42M | -6.63%170.47M | -4.98%804.74M | -1.53%535.1M |
| Operating revenue | 13.28%753.62M | 7.19%506.29M | 0.22%322.13M | -6.52%159.36M | -17.33%665.28M | -11.73%472.32M | -12.86%321.42M | -6.63%170.47M | -4.98%804.74M | -1.53%535.1M |
| Other operating revenue | -13.80%16.59M | ---- | 0.39%9.2M | ---- | 75.09%19.25M | ---- | 149.49%9.17M | ---- | 108.44%10.99M | ---- |
| Total operating cost | 14.76%706.86M | 11.87%487.69M | 2.88%304.31M | -10.11%142.58M | -21.19%615.95M | -17.83%435.95M | -18.23%295.79M | -7.86%158.63M | 3.71%781.58M | 9.75%530.55M |
| Operating cost | 19.69%400.2M | 11.07%266.51M | 3.94%164.41M | -2.60%80.19M | -18.94%334.36M | -14.53%239.95M | -17.55%158.18M | -12.70%82.33M | -3.64%412.5M | 1.51%280.75M |
| Operating tax surcharges | 3.24%5.07M | -21.81%2.62M | -29.89%1.47M | -69.23%442.2K | -17.60%4.91M | -2.65%3.35M | -11.56%2.09M | 7.67%1.44M | 17.50%5.95M | -3.43%3.44M |
| Operating expense | 16.48%209.5M | 19.63%145.43M | 4.28%91.6M | -18.00%37.58M | -29.03%179.85M | -27.65%121.57M | -21.68%87.84M | -4.57%45.84M | 17.12%253.43M | 26.44%168.02M |
| Administration expense | -4.59%60.16M | -8.45%44.13M | -10.11%30.34M | -6.65%16.3M | -18.60%63.06M | -17.80%48.21M | -15.23%33.75M | -10.98%17.46M | 13.11%77.47M | 25.25%58.64M |
| Financial expense | -9.05%-6.84M | 83.93%-998.88K | 40.80%-3.54M | -610.15%-1.59M | -159.02%-6.27M | 5.48%-6.21M | -97.11%-5.97M | -67.20%310.97K | -150.25%-2.42M | -330.56%-6.58M |
| -Interest expense (Financial expense) | 4.54%2.7M | -6.23%1.88M | -30.43%1M | -47.56%415.24K | -25.10%2.59M | -19.07%2.01M | -10.13%1.44M | -0.30%791.77K | 5.43%3.45M | 5.73%2.48M |
| -Interest Income (Financial expense) | 19.40%-6.38M | 19.08%-4.68M | 22.71%-3.13M | 35.67%-1.5M | -322.47%-7.92M | -361.26%-5.78M | -350.81%-4.06M | -363.96%-2.33M | -13.72%-1.87M | 5.58%-1.25M |
| Research and development | -3.17%38.77M | 3.12%30.01M | 0.63%20.02M | -14.18%9.65M | 15.55%40.04M | 10.73%29.1M | 7.02%19.9M | 42.11%11.25M | 12.58%34.65M | 26.75%26.28M |
| Credit Impairment Loss | -275.84%-559.16K | 146.99%105.54K | -160.49%-160.85K | -165.68%-237.1K | 63.29%317.99K | -161.01%-224.6K | -42.75%265.92K | -41.13%360.99K | 188.23%194.74K | 251.33%368.15K |
| Asset Impairment Loss | -142.11%-520.64K | -50.16%607.33K | -82.46%264.19K | -101.29%-12.45K | 145.65%1.24M | 260.74%1.22M | 278.45%1.51M | --966.05K | -92.29%-2.71M | -166.94%-758.11K |
| Other net revenue | -6.77%27.3M | 5.97%21.93M | 7.49%16.38M | 18.59%9.29M | 11.14%29.28M | 2.14%20.7M | 4.04%15.24M | 31.51%7.84M | 0.85%26.35M | -1.41%20.26M |
| Fair value change income | -115.36%-254.79K | -147.57%-835.52K | -131.45%-605.62K | -206.62%-1.18M | 127.73%1.66M | -59.05%1.76M | -65.80%1.93M | -35.84%1.11M | 157.08%728.28K | 141.17%4.29M |
| Invest income | -4.69%7.39M | 13.89%7M | 71.21%4.95M | 286.53%3.8M | 1,073.69%7.76M | 240.19%6.15M | 184.57%2.89M | 125.28%982.96K | -107.98%-796.58K | -175.22%-4.39M |
| Asset deal income | 109.59%43.52K | -227.00%-104.51K | -116.04%-88.36K | 107.38%4.26K | -125.41%-453.9K | -27.55%82.29K | -17,105.91%-40.9K | ---57.68K | -167.11%-201.37K | 262.55%113.59K |
| Other revenue | 12.95%21.2M | 29.38%15.16M | 38.30%12.03M | 54.49%6.92M | -35.57%18.77M | -43.23%11.72M | -32.13%8.7M | -40.38%4.48M | 55.33%29.13M | 53.53%20.63M |
| Operating profit | -5.80%74.06M | -28.97%40.53M | -16.30%34.21M | 32.45%26.06M | 58.80%78.62M | 130.02%57.06M | 87.77%40.87M | 20.20%19.68M | -58.53%49.51M | -69.20%24.81M |
| Add:Non operating Income | 26.47%595.83K | -41.48%254.79K | 40.66%184.86K | -55.25%23.1K | -74.93%471.12K | -69.25%435.37K | -85.54%131.43K | -76.88%51.63K | 78.64%1.88M | 224.64%1.42M |
| Less:Non operating expense | -26.44%453.51K | -15.70%405.25K | -8.05%368.05K | 708.25%173.47K | -47.45%616.51K | -30.90%480.74K | -39.60%400.27K | -92.63%21.46K | -65.08%1.17M | -76.91%695.72K |
| Total profit | -5.44%74.2M | -29.18%40.38M | -16.20%34.02M | 31.48%25.91M | 56.28%78.47M | 123.35%57.02M | 84.44%40.6M | 20.89%19.71M | -57.11%50.21M | -67.25%25.53M |
| Less:Income tax cost | -34.05%4.69M | -67.87%1.5M | -29.01%2.11M | 58.69%3.32M | 119.38%7.12M | 493.41%4.66M | 635.44%2.97M | 1,453.94%2.09M | -62.28%3.24M | -112.82%-1.18M |
| Net profit | -2.59%69.51M | -25.74%38.88M | -15.19%31.92M | 28.25%22.59M | 51.92%71.36M | 96.01%52.36M | 66.76%37.63M | 7.04%17.62M | -56.71%46.97M | -61.13%26.71M |
| Net profit from continuing operation | -2.59%69.51M | -25.74%38.88M | -15.19%31.92M | 28.25%22.59M | 51.92%71.36M | 96.01%52.36M | 66.76%37.63M | 7.04%17.62M | -56.71%46.97M | -61.13%26.71M |
| Net profit of parent company owners | -2.59%69.51M | -25.74%38.88M | -15.19%31.92M | 28.25%22.59M | 51.92%71.36M | 96.01%52.36M | 66.76%37.63M | 7.04%17.62M | -56.71%46.97M | -61.13%26.71M |
| Earning per share | ||||||||||
| Basic earning per share | -2.24%0.2138 | -25.50%0.1195 | -15.09%0.0979 | 28.15%0.0692 | 51.88%0.2187 | 95.85%0.1604 | 66.62%0.1153 | 6.93%0.054 | -56.72%0.144 | -61.13%0.0819 |
| Diluted earning per share | -2.24%0.2138 | -25.50%0.1195 | -15.09%0.0979 | 28.15%0.0692 | 51.88%0.2187 | 95.85%0.1604 | 66.62%0.1153 | 6.93%0.054 | -56.72%0.144 | -61.13%0.0819 |
| Other composite income | ||||||||||
| Total composite income | -2.59%69.51M | -25.74%38.88M | -15.19%31.92M | 28.25%22.59M | 51.92%71.36M | 96.01%52.36M | 66.76%37.63M | 7.04%17.62M | -56.71%46.97M | -61.13%26.71M |
| Total composite income of parent company owners | -2.59%69.51M | -25.74%38.88M | -15.19%31.92M | 28.25%22.59M | 51.92%71.36M | 96.01%52.36M | 66.76%37.63M | 7.04%17.62M | -56.71%46.97M | -61.13%26.71M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | -- | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.